Justia Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

Applicant Sturgeon loses 101 case on floral arrangements

12 Jan 2021, 4:23 pm by Lawrence B. Ebert

Ltd. v. [read post]

Prometheus Based Patent Reexamination Requests?

7 May 2012, 1:10 am by Scott A. McKeown

Last Monday, Merial Ltd, the animal health division of Sanofi Aventis, filed a request for ex parte reexamination of Genetic Technologies U.S. [read post]

Patents Post-Grant - http://www.patentspostgrant.com

Narrowing Amendment Specifying DNA From Specific Viral Strains Precluded Application of Doctrine of Equivalents to Encompass Other DNA

14 Aug 2009, 12:35 am

Merial Ltd. et al., 1-06-cv-00658 (DCD August 12, 2009, Memorandum Opinion)(Kennedy, J.) [read post]

Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/

District Court Determines No Personal Jurisdiction Exists Under Rules (4)(k)(1) and (4)(k)(2) of the Federal Rules of Civil Procedure Where Plaintiff Could Show Only a Single Infringing Unit Was Sold in the State and Defendant’s Website and Other Activities Were Not Directed at Residents of the State

8 May 2020, 11:00 am by Stan Gibson and Julia Consoli-Tiensvold

”[1] Merial Ltd. v. [read post]

Patent Lawyer Blog - http://patentlaw.jmbm.com/

Pharma & Biotech Global Week in Review 18 August 2010 from IP Think Tank

18 Aug 2010, 12:19 am by Kelly

Merial Ltd. [read post]

IP Thinktank - http://duncanbucknell.com/ipthinktank.blog

Pharma & Biotech Global Week in Review 17 November 2010 from IP Think Tank

17 Nov 2010, 1:48 am by Kelly

Highlights this week included: Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]

IP Thinktank - http://duncanbucknell.com/ipthinktank.blog

False Marking False Marking False Marking False Marking all at up to $500 per offense

26 Feb 2010, 4:17 pm by Dennis Crouch

Merial L.L.C. et al; Simonian v. [read post]

Patently-O - http://www.patentlyo.com/patent/

ANDA filing creates Nationwide Personal Jurisdiction

18 Mar 2016, 8:10 am by Dennis Crouch

See Merial Ltd. v. [read post]

Patently-O - http://patentlyo.com/patent

Patent Docs on Cleveland Clinic. Matter of cherry-picking.

28 Jun 2017, 8:30 am by Lawrence B. Ebert

Ltd. v. [read post]

IPBiz - http://ipbiz.blogspot.com/

Pharma & Biotech Global Week in Review 11 August 2010 from IP Think Tank

10 Aug 2010, 8:44 pm by Marie Louise

Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]

IP Thinktank - http://duncanbucknell.com/ipthinktank.blog

Guest Post: An Interesting Preview of Myriad?

26 Sep 2010, 7:29 pm by Dennis Crouch

Merial Ltd., decided by a Federal Circuit panel on August 4. [read post]

Patently-O - http://www.patentlyo.com/patent/

Futurewei v. Acacia Research: First-to-File Forum Rule Determines Fate of Same Co-Pending Cases Filed One Day Apart

4 Dec 2013, 7:06 am

Merial Ltd. v. [read post]

Journal of the Patent and Trademark Office Society - http://jptos.org

Pharma & Biotech Global Week in Review 22 September 2010 from IP Think Tank

21 Sep 2010, 7:47 pm by Kelly

: AMP et al v USPTO et al; Intervet v Merial (ipeg) US: OGD has put the brakes on ANDA supplement reviews; Will it help push generic drug user fees along? [read post]

IP Thinktank - http://duncanbucknell.com/ipthinktank.blog

Pharma & Biotech Global Week in Review 24 Feb 2010 from IP Think Tank

24 Feb 2010, 2:11 am

(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]

IP Thinktank - http://duncanbucknell.com/ipthinktank.blog

Attack on Helferich Patent Licensing/Wireless Science Patent, Among the Reexamination Requests Filed Week of May 7, 2012

7 May 2012, 10:00 pm by Stephanie Figueroa

Filed April 30, 2012, by Merial, Ltd. [read post]

Patent Law Practice Center - http://patentlawcenter.pli.edu/

Pharma & Biotech Global Week in Review 24 Feb 2010 from IP Think Tank

24 Feb 2010, 2:11 am

(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]

IP Thinktank - http://duncanbucknell.com/ipthinktank.blog

Attack on Helferich Patent Licensing/Wireless Science Patent, Among the Reexamination Requests Filed Week of May 7, 2012

7 May 2012, 10:00 pm by Stephanie Figueroa

Filed April 30, 2012, by Merial, Ltd. [read post]

Patent Law Practice Center - http://patentlawcenter.pli.edu

U.S. Court of Appeals for the Federal Circuit, Communications Test Design, Inc. v. Contec, LLC, Docket No. 2019-1672

25 Mar 2020, 3:00 pm

” Merial Ltd. v. [read post]

Frederic Borel - http://fredericborel.blogspot.ch/

Written Description: Showing “Possession” of a Negative Limitation

28 Jul 2013, 12:48 pm by Dennis Crouch

In 2009, a competitor (Merial Ltd., a Sanofi compani) filed an ex parte reexamination request. [read post]